A A A A
 
Pages
Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Posts
Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Menu
 
 
Home | Team Members | Jeff Evans
 


Department:
Director

Institution:
University of Glasgow

Jeff Evans

Director, Institute of Cancer Sciences, University of Glasgow 
Lead, Glasgow Experimental Cancer Medicine Centre.
Head, Experimental Cancer Therapeutics Unit, University of Glasgow
Honorary Group Leader, CRUK Beatson Institute

Precision-Panc Grantholder

Jeff’s research focuses on the pre-clinical and clinical development of novel cancer therapeutics, specifically how to exploit laboratory models to determine the biological function of key tumour suppressor genes and oncogenes in both normal tissues and tumours. This will allow the identification and characterisation of the signalling pathways that are deregulated at the early stages of pancreatic cancer as well as during the development and progression of the invasive and metastatic phenotype, and the role of the tumour microenvironment in these processes. The models will also be used to determine how potential anticancer agents might best be evaluated in subsequent clinical trials. He leads Phase I – Phase III clinical trials in pancreatic cancer in Glasgow and is a member of the NCRI pancreatic cancer sub-group.

Contributor: Pre-Clinical Therapeutics

Specialist knowledge: Oncology, cancer research, clinical research, molecular biology, translational research, clinical trials, pre-clinical cancer models, immunotherapy

© 2019 Precision Panc
Web design by Creatomatic
This site uses cookies.
Configure
 
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.